The year 2019, which continued the trend of rapid and numerous changes in healthcare regulations, was rich on expectations, events and legislative proposals aiming to reverse pharmaceutical industry: medical drugs labeling, reform of price determination, new procedure of entry into drugs civil circulation, amendments to regulatory framework of the Eurasian Economic Union, etc. This trend is likely to continue in 2020 as well.

The new review of the most notable patents disputes in Life Sciences in EAEU, CIS and Eastern Europe.

• pdf, 791.73 kb

Under the Decree of the Government of the Russian Federation No. 1556 dated December 14, 2018 (hereinafter — Decree No. 1556), monitoring system of the medical drugs circulation should become effective from the January 2020 with the exception of medical drugs for healing high-cost ICD diseases, which have already been monitored from October1, 2019.

Ritz Carlton Moscow, December 5th 2019. The results of the annual Pravo.ru-300 law firms’ ranking were announced at an awarding ceremony at the Ritz Carlton Moscow.

In September the draft law was amended with a new provision on the creation of Register of pharmacologically active substances. Under this provision, Rospatent will keep the publicly available Register of pharmacologically active substances protected by patent.

The new review of the most notable patents disputes in Life Sciences in EAEU, CIS and Eastern Europe.

• pdf, 766.11 kb

Partner of the Lidings’ Intellectual Property practice Boris Malakhov will take part in a C5’s Pharmaceutical Patent Term Extensions conference scheduled to take place on 25-26 of June 2019 in Munich.

Lidings’ Intellectual Property practice Associate Roman Vlasov will run a webinar on Using Personal Data of Clients: How to Handle and Avoid Claims from Roskomnadzor organized by Caselook.

Lidings’ Associate Nadezhda Fedotova will speak at a conference entitled “Labeling in Pharmaceutical Industry”. The event will take place in Moscow on May 24th at Ararat Park Hyatt Hotel.